Alpha Teknova (TKNO) Other financing activities (2021 - 2026)
Alpha Teknova's (TKNO) quarterly Other financing activities came in at $9000.0 in Q1 2026, up 125.0% year-on-year from $4000.0 in Q1 2025, and down 82.35% on a QoQ basis from $51000.0 in Q4 2025.
Alpha Teknova (TKNO) Other financing activities (2021 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 6 years of Other financing activities data on file, last reported at $9000.0 in Q1 2026.
- On a quarterly basis, Other financing activities rose 125.0% year-over-year to $9000.0 in Q1 2026; TTM through Mar 2026 was $105000.0, a 24.46% decrease from a year earlier, with the FY2025 full-year figure at $100000.0, down 25.93% from the prior year.
- Other financing activities for Q1 2026 stood at $9000.0, down from $51000.0 in the prior quarter.
- Over the last five years, Other financing activities for TKNO reached as high as $150000.0 in Q4 2022 and fell as low as -$51000.0 in Q3 2024.
- Historically, Other financing activities has averaged $52666.7 across 5 years, with a median of $54000.0 in 2024.
- Across the five-year window, Other financing activities plunged 182.26% in 2024 and soared 156.86% in 2025, its largest moves.
- Year by year, Other financing activities stood at $150000.0 in 2022, then fell by 24.0% to $114000.0 in 2023, then tumbled by 52.63% to $54000.0 in 2024, then fell by 5.56% to $51000.0 in 2025, then sank by 82.35% to $9000.0 in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were $9000.0 in Q1 2026, $51000.0 in Q4 2025, and $29000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,000.00 |
| Mar 31, 2026 | 9,000.00 |
| Dec 31, 2025 | 51,000.00 |
| Dec 31, 2025 | 51,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 16,000.00 |
| Jun 30, 2025 | 16,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Sep 30, 2024 | -51,000.00 |
| Sep 30, 2024 | -51,000.00 |
| Jun 30, 2024 | 132,000.00 |
| Jun 30, 2024 | 132,000.00 |
| Dec 31, 2023 | 114,000.00 |
| Dec 31, 2023 | 114,000.00 |
| Sep 30, 2023 | 62,000.00 |
| Sep 30, 2023 | 62,000.00 |